Evidence map›Paper›PMID 41771888›Full record

ArticleNature communications2026

A single mutation in nonstructural protein 1 is critical for the adaptive evolution of influenza B virus.

Pengtao Jiao, Xiaoxiao Jia, Xiaoyuan Bai, Yuna Zhao, Runshan Lin, Zeqiu Fan, Wenhui Fan, He Zhang, Heqiao Li, Yuhai Bi and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Pengtao Jiao *Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Xiaoxiao Jia *Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Xiaoyuan Bai *Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Yuna Zhao *Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Runshan LinShenzhen Medical Academy of Research and Translation (SMART), Shenzhen, Guangdong, China.
Zeqiu FanKey Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Wenhui FanKey Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
He ZhangShenzhen Medical Academy of Research and Translation (SMART), Shenzhen, Guangdong, China.
Heqiao LiInstitute of Infectious Diseases, Shenzhen Bay Laboratory, Shenzhen, Guangdong, China.
Yuhai BiKey Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.ORCID http://orcid.org/0000-0002-5595-363X
Dayan WangChinese National Influenza Center (CNIC), National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China.
Wenjun LiuKey Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
Lei SunKey Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China. sunlei362@im.ac.cn.ORCID http://orcid.org/0000-0003-0141-2093

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32061123001
6 · The paper itself

Abstract

Influenza B virus (IBV) has circulated in the human population for a long time, yet the evolutionary mechanisms responsible for host adaptation remain poorly understood. Here we show that recent IBV strains exhibit an enhanced ability to evade the innate immune response and an increased replication efficiency compared with earlier strains. Our data indicate that the nonstructural protein 1 (NS1) of recent IBV strains interacts with TUFM and LC3B to induce mitophagy, leading to degradation of MAVS, suppression of interferon production and enhanced viral replication. In contrast, NS1 of earlier strains displays minimal ability to trigger mitophagy-mediated MAVS degradation. Sequence analyses show that, over the past two decades, IBV has acquired a phenylalanine (F)-to-leucine (L) substitution at residue 247 of NS1, altering its interaction with LC3B. A rescued recent IBV strain carrying the NS1-L247F mutation exhibits diminished NS1-LC3B binding, impaired mitophagy, and attenuated replication. Our study shows that adaptive evolution involving a single mutation in NS1 enables mitophagy-mediated innate immune evasion, contributing to IBV adaptation to the host.

Indexed as

Influenza B virusViral Nonstructural ProteinsAnimalsDogsEvolution, MolecularHEK293 CellsHumansImmune EvasionImmunity, InnateInfluenza, HumanMadin Darby Canine Kidney CellsMitophagyMutationVirus ReplicationINS1 protein, influenza virusViral Nonstructural Proteins

Identifiers

PMID41771888
PMCPMC13066462

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.